Tempest Therapeutics
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$29,491,000 over the previous period. Total operating expenses were $29,157,000.

Profit Margin

Tempest Therapeutics, Inc. (NASDAQ:TPST): Profit margin
2014 9.73M -49.52M -508.68%
2015 277K -73.21M -26432.85%
2016 653K -82.26M -12597.24%
2017 295K -84.57M -28670.51%
2018 0 -27.19M
2019 0 -44.56M
2020 0 -19.11M
2021 0 -29.55M
2022 0 -36.77M
2023 0 -29.49M

TPST Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
000000295K653K277K9.73M
Cost of revenue
381K1.81M1.27M815K1.05M028K5.40M2.24M0
Gross profit
-381K-1.81M-1.27M-815K-1.05M0267K-4.74M-1.97M9.73M
Operating exp.
Research and development
17.49M22.52M17.16M14.38M27.84M14.42M14.52M21.64M18.43M21.78M
Selling and marketing
000016.49M0-21.81M000
Total operating expenses
29.15M34.64M26.98M19.29M44.34M26.87M20.45M70.86M70.02M47.93M
Operating income
-29.15M-34.64M-26.98M-19.29M-45.39M-26.87M-20.48M-75.61M-71.99M-47.93M
Other income (expenses), net
-334K-1.06M-1.31M90K831K-303K-64.10M-6.44M-1.14M-1.58M
Income before tax
-29.49M-35.70M-28.30M-19.20M-44.56M-27.17M-84.58M-82.05M-73.14M-49.52M
Income tax expense
01.06M1.24M-90K1K-169K67K201K75K-1.58M
Net income
-29.49M-36.77M-29.55M-19.11M-44.56M-27.19M-84.57M-82.26M-73.21M-49.52M
Earnings per share
Basic EPS
-1.91-3.18-7.8-612.56-48.77-270.15-72.40K-817.26-608.25-491.98
Diluted EPS
-1.91-3.18-7.8-612.56-48.77-270.15-72.40K-817.26-608.25-491.98
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source